Clinical Trial Update: Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and Rosuvastatin [Phase 1]

View source ↗

Summary

Phase 1 trial update on the safety and pharmacokinetics of YHP1604 compared to the co-administration of Telmisartan/Amlodipine and Rosuvastatin; the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertension

Drugs mentioned

• Rosuvastatin (rosuvastatin)
• Telmisartan/Amlodipine (telmisartan and amlodipine)
• YHP1604

Snippet

Sponsor: Yuhan Corporation | Conditions: Hypertension, Hyperlipidemia | Phase 1 | Status: COMPLETED